Research graph
References from Therapists’ Perspectives on the Psychotherapeutic Support in Psilocybin Treatment for Major Depressive Disorder: Insights from a Randomized Controlled Trial. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Major depressive disorder: Hypothesis, mechanism, prevention and treatment
10.1038/s41392-024-01738-y · 2024 · External reference
Efficacy of psilocybin for treating symptoms of depression: Systematic review and meta-analysis
10.1136/bmj-2023-078084 · 2024 · External reference
Classical psychedelics in therapy: Essential psychotherapy or minimal support?
10.1016/j.euroneuro.2025.01.004 · 2025 · External reference
Unresolved reference
2024 · External reference
The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects
10.1021/acsptsci.0c00192 · 2021 · External reference
The subjective effects of psychedelics are necessary for their enduring therapeutic effect
10.1021/acsptsci.0c00194 · 2021 · External reference
Must psilocybin always assist psychotherapy?
10.1176/appi.ajp.20221043 · 2024 · External reference
Misinterpretations and omissions: A critical response to Goodwin and colleagues' commentary on psilocybin-assisted therapy
10.1176/appi.ajp.20230661 · 2024 · External reference
Protocols and practices in psilocybin-assisted psychotherapy for depression: A systematic review
10.1016/j.jpsychires.2024.05.051 · 2024 · External reference
Quality of reporting on psychological interventions in psychedelic treatments: A systematic review
10.1016/s2215-0366(24)00333-x · 2025 · External reference
In psychedelic-assisted therapy, the alliance in the psychotherapy component is as important as the drug
10.1159/000546270 · 2025 · External reference
A dose of therapy with psilocybin: A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy
10.1016/j.genhosppsych.2025.07.020 · 2025 · External reference
Psychological therapy quantity and depressive symptom reduction in psychedelic-assisted therapy: A systematic review and meta-analysis
10.1001/jamanetworkopen.2025.54843 · 2026 · External reference
The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: A Bayesian meta-analysis
10.3389/fpsyt.2024.1439347 · 2024 · External reference
A. Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: A qualitative analysis
10.1186/s12954-025-01347-0 · 2025 · External reference
Lost in translation? Qualitative interviews with Australian psychedelic-assisted therapy trial clinicians
10.1111/papt.12545 · 2024 · External reference
Perspectives of psychotherapists regarding psychedelic assisted therapy
10.1002/capr.12881 · 2025 · External reference
Psilocybin-assisted therapy: A scoping review of participants' and facilitators' experiences in qualitative studies
10.33448/rsd-v12i9.43308 · 2023 · External reference
Understanding psychedelic-assisted psychotherapy providers’ perspective and insights: A qualitative analysis
10.1089/psymed.2023.0074 · 2024 · External reference
Acute and late effects of psilocybin on symptoms in major depression: A randomized clinical trial
10.1001/jamanetworkopen.2026.12589 · 2026 · External reference
A new depression scale designed to be sensitive to change
10.1192/bjp.134.4.382 · 1979 · External reference
Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review
10.1177/02698811251338214 · 2025 · External reference
Unresolved reference
2022 · External reference
Thematic analysis: Striving to meet the trustworthiness criteria
10.1177/1609406917733847 · 2017 · External reference
Neuropharmacological modulation of the aberrant bodily self through psychedelics
10.1016/j.neubiorev.2019.12.006 · 2020 · External reference
Embodiment and psychopathology: A phenomenological perspective
10.1097/yco.0b013e3283318e5c · 2009 · External reference
Patient experiences of psilocybin-assisted psychotherapy: An interpretative phenomenological analysis
10.1177/0022167817706884 · 2017 · External reference
Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder
10.3389/fphar.2018.00100 · 2018 · External reference
Patients’ accounts of increased connectedness and acceptance after psilocybin for treatment-resistant depression
10.1177/0022167817709585 · 2017 · External reference
Psychedelic experiences in psychedelic-assisted therapy for depression
10.1080/09515089.2024.2378845 · 2025 · External reference
Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression
10.1186/s12909-026-09124-8 · 2026 · External reference
Developing guidelines and competencies for the training of psychedelic therapists
10.1177/0022167817711304 · 2017 · External reference
The elephant in the room: Personal use of psychedelics among psychedelic researchers
10.1089/psymed.2023.29002.psh · 2023 · External reference
Substance abuse counselors with and without a personal history of chemical dependency: A review of the literature
10.1300/j020v18n02_05 · 2000 · External reference
Control group outcomes in trials of psilocybin, SSRIs, or esketamine for depression: A meta-analysis
10.1001/jamanetworkopen.2025.24119 · 2025 · External reference
